||Prof. Dr. Christof Hettich has been on the board of directors since Cytonet was founded in 2000 and has been its chairman since 2005. He studied law in Freiburg, Würzburg and Mannheim and assisted at the chair of tax law at the University of Mannheim under Prof. Arndt. His specialty is corporate business structure, with a focus on corporate and tax law. After obtaining his doctorate, he joined the Mannheim law firm Rittershaus Attorneys at Law in 1990, where he became a full partner three years later. Hettich is also founder and CEO of dievini Hopp BioTech Holding GmbH & Co. KG and chairman or board member in several listed companies. Hettich is a close confidant of Dietmar Hopp, Cytonet’s majority shareholder and co-founder of SAP in Walldorf/Germany.
Prof. Dr. Thomas Boehm, Max Planck Institute for Immunobiology, Freiburg
Prof. Dr. Friedrich von Bohlen und Halbach, General Manager of dievini Hopp BioTech holding GmbH & Co. KG, Walldorf
Dr. Mathias Hothum, General manager of dievini Hopp BioTech holding GmbH & Co. KG, Walldorf
Martin Meisiek, Roche Diagnostics GmbH, Mannheim
Prof. Dr. Vicente Arroyo-Perez, Hospital Clinico y Provincial, University of Barcelona
Univ.-Prof. Dr., Prof. h.c. (RCH) Georg. F. Hoffmann, managing director of the Center for Pediatric Medicine, Heidelberg University Hospital, honorary professorship at Tongji University Wuhan, China
Prof. Dr. med. Michael P. Manns, director of the Clinic for Gastroenterology, Hepatology and Endocrinology, Center of Internal Medicine, Hanover Medical School (MHH)